Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients
Authors
Keywords
-
Journal
Asian Journal of Psychiatry
Volume 79, Issue -, Pages 103400
Publisher
Elsevier BV
Online
2022-12-13
DOI
10.1016/j.ajp.2022.103400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine
- (2022) Xiaoping Yuan et al. PSYCHOPHARMACOLOGY
- Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia
- (2022) Antonio F. Pardiñas et al. JAMA Psychiatry
- Neuroimaging Biomarkers in Schizophrenia
- (2021) Nina V. Kraguljac et al. AMERICAN JOURNAL OF PSYCHIATRY
- Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
- (2021) Evgeny A. Ermakov et al. Oxidative Medicine and Cellular Longevity
- Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?
- (2021) Tongtong Zhao et al. PSYCHOPHARMACOLOGY
- Peripheral immune markers and antipsychotic non-response in psychosis
- (2021) Daniela Enache et al. SCHIZOPHRENIA RESEARCH
- Serum level of high sensitive C-reactive protein and IL − 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study
- (2021) Feyissa Challa et al. BMC Psychiatry
- Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia
- (2021) Zhi Wei Wu et al. PSYCHOSOMATIC MEDICINE
- Life expectancy and potential years of life lost for schizophrenia in western China
- (2021) Xiang Liu et al. PSYCHIATRY RESEARCH
- Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation
- (2021) Caleb Labonté et al. PSYCHIATRY RESEARCH
- Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis
- (2021) Xue Xin Goh et al. Asian Journal of Psychiatry
- Plasma Soluble P-selectin, Interleukin-6 and S100B Protein in Patients with Schizophrenia: a Pilot Study
- (2021) Omar F. Pinjari et al. PSYCHIATRIC QUARTERLY
- A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis
- (2020) Byron K.Y. Bitanihirwe et al. SCHIZOPHRENIA RESEARCH
- Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
- (2020) Yi-Ling Chien et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
- (2020) Shiguang Zhu et al. PSYCHONEUROENDOCRINOLOGY
- Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia
- (2020) Mei Hong Xiu et al. SCHIZOPHRENIA BULLETIN
- Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats
- (2020) Jana Lotter et al. Frontiers in Psychiatry
- Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection
- (2020) Pinku Mani Talukdar et al. MOLECULAR NEUROBIOLOGY
- A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States
- (2020) Michael Frank Mørup et al. PLoS One
- Association of cigarette smoking with cognitive impairment in male patients with chronic schizophrenia
- (2020) Shuochi Wei et al. PSYCHOPHARMACOLOGY
- Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia
- (2020) Dong Mei Wang et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments
- (2020) Arafat Hussein Al-Dujaili et al. SCHIZOPHRENIA BULLETIN
- Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders
- (2020) Sherry Kit Wa Chan et al. SCHIZOPHRENIA BULLETIN
- Longitudinal study of inflammatory markers and psychopathology in schizophrenia
- (2020) Tami Feng et al. SCHIZOPHRENIA RESEARCH
- Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia
- (2020) Li Mu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Clinical indicators of treatment-resistant psychosis
- (2019) Sophie E. Legge et al. BRITISH JOURNAL OF PSYCHIATRY
- The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
- (2019) Chutima Roomruangwong et al. MOLECULAR NEUROBIOLOGY
- Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies
- (2019) S. E. Smart et al. PSYCHOLOGICAL MEDICINE
- Ultra-Treatment Resistant Schizophrenia- Where Do We Stand?
- (2019) Ahmed Naguy et al. Asian Journal of Psychiatry
- Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists
- (2019) Christoph U. Correll et al. BMC Psychiatry
- Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
- (2019) Ankita Nandi et al. Oxidative Medicine and Cellular Longevity
- Treatment-resistant schizophrenia: focus on the transsulfuration pathway
- (2019) Thomas Berry et al. REVIEWS IN THE NEUROSCIENCES
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients – A randomized controlled trial
- (2018) Ning Ding et al. NEUROSCIENCE LETTERS
- Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016
- (2018) Fiona J Charlson et al. SCHIZOPHRENIA BULLETIN
- Biomarcadores de estrés oxidativo y dimensiones clínicas en los 10 primeros años de esquizofrenia
- (2018) Leticia González-Blanco et al. Revista de Psiquiatria y Salud Mental
- The validity and sensitivity of PANSS-6 in treatment-resistant schizophrenia
- (2018) S. D. Østergaard et al. ACTA PSYCHIATRICA SCANDINAVICA
- Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis
- (2018) David Fraguas et al. SCHIZOPHRENIA BULLETIN
- Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia
- (2018) Zhi-Le Bai et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Repeated Restraint Stress Decreases Na,K-ATPase Activity via Oxidative and Nitrosative Damage in the Frontal Cortex of Rats
- (2018) Leonardo Santana Novaes et al. NEUROSCIENCE
- Oxidative and nitrosative stress biomarkers in chronic schizophrenia
- (2017) Karine Maria Boll et al. PSYCHIATRY RESEARCH
- Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
- (2017) Milica Milovan Borovcanin et al. Frontiers in Psychiatry
- GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients
- (2017) Denise S. Pinheiro et al. PLoS One
- Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders
- (2016) Wolfgang Jordan et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
- (2016) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development
- (2015) M. Möller et al. ACS Chemical Neuroscience
- The role of antioxidants in the chemistry of oxidative stress: A review
- (2015) Aurelia Magdalena Pisoschi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders
- (2015) Gerwyn Morris et al. MOLECULAR NEUROBIOLOGY
- The interplay between BDNF and oxidative stress in chronic schizophrenia
- (2015) Xiang Yang Zhang et al. PSYCHONEUROENDOCRINOLOGY
- High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
- (2015) Cristiano Noto et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
- (2014) Mark D. Turner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Maternal immune activation leads to age-related behavioral and immunological changes in male rat offspring - the effect of antipsychotic drugs
- (2014) Agnieszka Basta-Kaim et al. Pharmacological Reports
- Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs
- (2013) Meng-Chang Tsai et al. PSYCHIATRY RESEARCH
- Oxidative stress induces gastric submucosal arteriolar dysfunction in the elderly
- (2013) Lei Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
- (2012) Takefumi Suzuki et al. PSYCHIATRY RESEARCH
- Association of FAS, a TNF-α receptor gene, with treatment resistant schizophrenia
- (2011) Peilin Jia et al. SCHIZOPHRENIA RESEARCH
- Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models
- (2010) Yuichiro Watanabe et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
- (2009) Xiang Yang Zhang et al. PSYCHOPHARMACOLOGY
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice
- (2008) Haruhiko Sugino et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now